Premium
The impact of fibrinolytic therapy for ST‐segment‐elevation acute myocardial infarction
Author(s) -
VAN DE WERF F. J.,
TOPOL E. J.,
SOBEL B. E.
Publication year - 2009
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2008.03195.x
Subject(s) - fibrinolytic therapy , medicine , myocardial infarction , reperfusion therapy , cardiology , tissue plasminogen activator , plasminogen activator , fibrinolytic agent , intensive care medicine , fibrinolysis
Summary. As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue‐plasminogen activator (t‐PA) more particularly and the current indications for its use in the era of mechanical reperfusion.